Don't underestimate the vaccines, I'm more then happy for them to continue them, just as long as they manage the cash burn with them, which seems they may be doing that by delaying the start of the HPV trial abit.
The vaccines could make the patch secondary for this company.
- Forums
- ASX - By Stock
- AVR
- Vaxxas secures funding interest to see if professor Fraser utilizes nanopatch
Vaxxas secures funding interest to see if professor Fraser utilizes nanopatch, page-44
-
-
- There are more pages in this discussion • 74 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$14.25 |
Change
0.000(0.00%) |
Mkt cap ! $301.2M |
Open | High | Low | Value | Volume |
$14.20 | $14.76 | $13.70 | $355.0K | 25.04K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 988 | $14.25 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.99 | 1000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 988 | 14.250 |
1 | 499 | 14.150 |
2 | 700 | 14.050 |
1 | 113 | 14.000 |
1 | 1000 | 13.900 |
Price($) | Vol. | No. |
---|---|---|
14.990 | 1000 | 1 |
15.150 | 149 | 1 |
15.500 | 44 | 1 |
15.700 | 277 | 1 |
15.880 | 250 | 1 |
Last trade - 16.10pm 12/08/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |